Sage Therapeutics Cash Flow Statement

Financials in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 30, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Net Income	-0.35	-0.2	-0.29	-0.17	-0.07
Change in Accounts Receivable	-0	0.02	-0.02	-0	-
Change in Accounts Payable	0.13	0.06	-0.12	0.12	0.07
Operating Cash Flow	-0.2	-0.13	-0.43	-0.05	-0
Capital Expenditures	-0.1	-	-0.03	-	-0.02
Investing Cash Flow	-0.1	-	-0.03	-	-0.02
Issuance of Common Stock	0.53	-	0.5	0.04	0.24
Other Financing Activities	-0.03	-	-0.07	-0.03	-
Financing Cash Flow	0.5	-	0.43	0.01	0.24
Net Cash Flow	0.2	-0.13	-0.02	-0.04	0.22
Free Cash Flow	-0.3	-0.13	-0.46	-0.05	-0.02
Free Cash Flow Per Share	-0.02	-0.01	-0.05	-0.01	-0.00
Levered Free Cash Flow	-0.14	-0.04	-0.3	0.02	-
Unlevered Free Cash Flow	-0.14	-0.04	-0.3	0.02	-
Change in Net Working Capital	-0.13	-0.08	0.14	-0.12	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.